InsiderTrades

Form 4 for BTSG BrightSpring Health Services, Inc.

Accepted 2024-01-30 00:00:00 ET · period of report 2024-01-25 · accession 0000950170-24-008837 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-01-30 2024-01-26 BTSG Barnes Robert Allen Pres, Community Living A - Grant $0.00 +46.6K 49.7K +1,492% $0
DM 2024-01-30 2024-01-25 BTSG Barnes Robert Allen Pres, Community Living A - Grant $0.00 +55.2K 106.0K +109% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-26 A A 46,620 $0.00 49,744 D — —
2 Derivative Stock Options (Right to Buy) 2024-01-25 A A 2,944 $0.00 8,832 D $7.01 · — to 2030-05-12 2,944 Common Stock (F3) Options acquired represent options originally granted on May 12, 2020, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing May 12, 2021. Reflects the Stock Split. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria.
3 Derivative Stock Options (Right to Buy) 2024-01-25 A A 16,919 $0.00 16,919 D $13.00 · — to 2034-01-25 16,919 Common Stock (F4) Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024.
4 Derivative Stock Options (Right to Buy) 2024-01-25 A A 35,331 $0.00 105,993 D $6.37 · — to 2029-09-24 35,331 Common Stock (F2) Options acquired represent options originally granted on September 24, 2019, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing March 5, 2020. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock (the "Stock Split"), which became effective on January 25, 2024. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria.